Benoit Gravel
Direktor/Vorstandsmitglied bei MEDEXUS PHARMACEUTICALS INC.
Vermögen: 65 939 $ am 31.05.2024
Profil
Benoit Gravel is an Independent Director at Medexus Pharmaceuticals, Inc. and a Member-Healthcare Council at Gerson Lehman Group (Asia) Ltd.
He was formerly the Chairman at The Public Sector Pension Investment Board, Director at Tm Bioscience Corp., Director at Lumira Capital Investment Management, Inc., Director-Corporate Planning & Business Development at Rhone-Poulenc Canada, Inc., Vice President-Global Portfolio Management at Zentiva Group as, Vice President-Commercial Affairs at Aventis Pasteur Ltd., and VP-Diabetes & Specialized Care Unit at Sanofi Canada, Inc. He received his undergraduate and graduate degrees from the University of Montréal.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.02.2024 | 56 358 ( 0,23% ) | 65 939 $ | 31.05.2024 |
Aktive Positionen von Benoit Gravel
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 22.09.2017 |
| Gerson Lehman Group (Asia) Ltd. | Corporate Officer/Principal | 01.04.2016 |
Ehemalige bekannte Positionen von Benoit Gravel
| Unternehmen | Position | Ende |
|---|---|---|
Zentiva Group as
 Zentiva Group as Pharmaceuticals: MajorHealth Technology Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic. | Corporate Officer/Principal | 01.02.2016 |
Sanofi Canada, Inc.
 Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Corporate Officer/Principal | 01.01.2014 |
| Rhone-Poulenc Canada, Inc. | Corporate Officer/Principal | 01.01.2000 |
| Aventis Pasteur Ltd. | Corporate Officer/Principal | - |
Tm Bioscience Corp.
 Tm Bioscience Corp. BiotechnologyHealth Technology Tm Bioscience Corp. developed DNA-based diagnostics tests. It developed a suite of genetic tests that include tests for genetic disorders, drug metabolism and infectious diseases. Tm Bioscience was founded on December 19, 1980 and was headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | - |
Ausbildung von Benoit Gravel
| University of Montréal | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Tm Bioscience Corp.
Tm Bioscience Corp. BiotechnologyHealth Technology Tm Bioscience Corp. developed DNA-based diagnostics tests. It developed a suite of genetic tests that include tests for genetic disorders, drug metabolism and infectious diseases. Tm Bioscience was founded on December 19, 1980 and was headquartered in Toronto, Canada. | Health Technology |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Finance |
Zentiva Group as
Zentiva Group as Pharmaceuticals: MajorHealth Technology Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic. | Health Technology |
The Public Sector Pension Investment Board
 The Public Sector Pension Investment Board Investment ManagersFinance The Public Sector Pension Investment Board (PSP Investments), locally known as Office d'investissement des régimes de pensions du secteur public, is a government-owned pension fund manager headquartered in Montreal, Canada. The firm was founded by the Public Sector Pension Investment Board Act in 1999. PSP Investments invest funds for the pension plans of the federal public service, the Canadian Armed Forces, the Royal Canadian Mounted Police and the Reserve Force. | Finance |
| Aventis Pasteur Ltd. | |
| Rhone-Poulenc Canada, Inc. | |
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Health Technology |
| Gerson Lehman Group (Asia) Ltd. |
